Evidence map›Paper›PMID 32639965›Full record

ArticlePloS one2020

Calcium-binding proteins are altered in the cerebellum in schizophrenia.

Francisco Vidal-Domènech, Gemma Riquelme, Raquel Pinacho, Ricard Rodriguez-Mias, América Vera, Alfonso Monje, Isidre Ferrer, Luis F Callado, J Javier Meana, Judit Villén and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Francisco Vidal-DomènechPsiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Gemma RiquelmePsiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Raquel PinachoPsiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Ricard Rodriguez-MiasDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America.
América VeraPsiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Alfonso MonjeParc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
Isidre FerrerDepartamento de Patologia y Terapeutica Experimental, Universidad de Barcelona, Senior consultant Servicio Anatomia Patológica, Hospital Universitario de Bellvitge-IDIBELL, CIBERNED, Hospital de Llobregat, Barcelona, Spain.
Luis F CalladoDepartment of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.
J Javier MeanaDepartment of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.
Judit VillénDepartment of Genome Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America.
Belén RamosPsiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.ORCID 0000-0002-4577-2106
Sant Joan de Déu Research Foundation · ESUniversitat Autònoma de Barcelona · ESUniversity of the Basque Country · ESUniversity of Washington · USBellvitge University Hospital · ESParc Sanitari Sant Joan de Déu · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations in the cortico-cerebellar-thalamic-cortical circuit might underlie the diversity of symptoms in schizophrenia. However, molecular changes in cerebellar neuronal circuits, part of this network, have not yet been fully determined. Using LC-MS/MS, we screened altered candidates in pooled grey matter of cerebellum from schizophrenia subjects who committed suicide (n = 4) and healthy individuals (n = 4). Further validation by immunoblotting of three selected candidates was performed in two cohorts comprising schizophrenia (n = 20), non-schizophrenia suicide (n = 6) and healthy controls (n = 21). We found 99 significantly altered proteins, 31 of them previously reported in other brain areas by proteomic studies. Transport function was the most enriched category, while cell communication was the most prevalent function. For validation, we selected the vacuolar proton pump subunit 1 (VPP1), from transport, and two EF-hand calcium-binding proteins, calmodulin and parvalbumin, from cell communication. All candidates showed significant changes in schizophrenia (n = 7) compared to controls (n = 7). VPP1 was altered in the non-schizophrenia suicide group and increased levels of parvalbumin were linked to antipsychotics. Further validation in an independent cohort of non-suicidal chronic schizophrenia subjects (n = 13) and non-psychiatric controls (n = 14) showed that parvalbumin was increased, while calmodulin was decreased in schizophrenia. Our findings provide evidence of calcium-binding protein dysregulation in the cerebellum in schizophrenia, suggesting an impact on normal calcium-dependent synaptic functioning of cerebellar circuits. Our study also links VPP1 to suicide behaviours, suggesting a possible impairment in vesicle neurotransmitter refilling and release in these phenotypes.

Indexed as

AdultCalcium-Binding ProteinsCalmodulinCase-Control StudiesCerebellumChromatography, High Pressure LiquidDown-RegulationFemaleHumansMaleMiddle AgedParvalbuminsProteomeSchizophreniaSuicide, AttemptedTandem Mass SpectrometryCalcium-Binding ProteinsCalmodulinParvalbuminsProteome

Identifiers

PMID32639965
PMCPMC7343173
OpenAlexW3042173284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.